세계의 약물 남용 치료 시장 : 유형별, 치료 유형별, 연령층별, 치료 환경별, 지역별

Global Substance Abuse Treatment Market, By Type, By Treatment Type, By Age Group, By Treatment Setting, By Geography

US $ 4,500 ￦ 6,458,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000 ￦ 10,046,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,352,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

약물 남용 치료 세계 시장은 2025년에 118억 2,000만 달러로 추정되며, 2032년에는 213억 3,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 8.8%의 성장률을 보일 것으로 예상됩니다.

보고서 범위		보고서 상세
기준 연도	2024년	2025년 시장 규모	118억 2,000만 달러
실적 데이터	2020년부터 2024년까지	예측 기간	2025년부터 2032년까지
예측 기간 : 2025-2032년 CAGR	8.80	2032년 가치 예측	213억 3,000만 달러

약물 남용 치료는 약물 의존을 관리하고 장기적인 금주 및 회복을 돕기 위한 프로그램 및 활동을 말합니다. 중독이라고도 알려진 물질 남용 장애는 유해하고 중독성이 있는 물질을 그 악영향에도 불구하고 강박적으로 또는 통제할 수 없을 정도로 사용하는 것을 포함합니다. 일반적인 남용 물질에는 알코올, 오피오이드, 대마초, 코카인, 각성제 등이 있습니다. 약물 남용 장애의 주요 증상으로는 섭취량을 줄일 수 없음, 갈망, 사용하지 않을 때 금단증상을 경험하는 것 등이 있습니다. 중독에 걸린 사람은 종종 자제력 저하, 사회적 문제, 위험한 사용, 때로는 신체적 의존을 경험하게 됩니다. 약물 남용 치료는 치료적 개입, 상담, 약물 치료, 지역 사회 지원 프로그램을 통해 중독의 생물학적, 심리적, 사회적, 행동적 측면을 다루는 것을 목표로 합니다. 전 세계적으로 약물 남용률이 증가함에 따라 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다.

시장 역학:

세계 약물 남용 치료 시장은 약물 남용 장애의 유병률 증가, 치료 효과에 대한 인식 증가, 유리한 규제 및 상환 정책, 새로운 약물 보조 치료 제품의 출시에 힘입어 성장하고 있습니다. 그러나 중독과 관련된 사회적 낙인, 저소득 지역의 치료 시설에 대한 접근성 부족, 치료 프로토콜 준수 위반 등의 문제로 인해 시장 성장이 제한될 수 있습니다. 디지털 치료 솔루션 개발, 통합 치료 모델, 특정 중독에 초점을 맞춘 치료, 신흥국 시장 진출은 시장 진입자에게 주요 비즈니스 기회가 될 것입니다. 지역적으로는 북미가 높은 수준의 의료 인프라와 인지도를 바탕으로 시장을 주도하고 있습니다. 그러나 아시아태평양은 예측 기간 동안 유리한 성장을 보일 것으로 예상됩니다.

본 조사의 주요 특징

• 세계의 약물 남용 치료 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서는 회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 약물 남용 치료 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 약물 남용 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 약물 남용 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 약물과 알코올 소비량 증가
• 정부와 NGO에서 지원 확대
  • 성장 억제요인
• 약물 의존 관련 사회적 편견
• 적절한 재활 시설의 부족
  • 기회
• 신흥 국가의 미개척 시장
• 기업의 시장 점유율 분석
• 주요 하이라이트
• 시장 동향
• PEST 분석
• PORTER의 분석
• 최근의 제품 승인/발매
• 합병, 인수 및 제휴

제4장 세계의 약물 남용 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 약물 남용 치료 시장, 유형별, 2020-2032년

• 알코올
• 오피오이드(예 : 헤로인, 처방 진통제)
• 담배/니코틴
• 코카인
• 마리화나
• 메스암페타민
• 기타 위법 약물(벤조디아제핀 등)

제6장 세계의 약물 남용 치료 시장, 치료 유형별, 2020-2032년

• 오피오이드
• 메사돈
• 부프레노르핀
• 서방형 날트렉손
• 로페키시진
• 니코틴
• 니코틴대체요법(패치, 흡입기, 껌으로서 이용 가능)
• 브프로피온
• 바레니클린
• 알코올
• 날트렉손
• 디설피람
• 아칸프로서트
• 담배
• 클로니딘
• 노르트리프치린
• 기타(트피라마트, 모다피닐 등)

제7장 세계의 약물 남용 치료 시장, 연령 그룹별, 2020-2032년

• 청소년
• 성인
• 노인

제8장 세계의 약물 남용 치료 시장, 치료 환경별, 2020-2032년

• 외래 치료
• 외래 진료소
• 개인 진료소
• 입원 치료
• 재활 센터
• 병원
• 주택 치료 시설
• 해독 센터

제9장 세계의 약물 남용 치료 시장, 지역별, 2020-2032년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제10장 경쟁 구도

• 기업 개요
  • Indivior PLC
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players

제11장 섹션

• 참고문헌
• 조사 방법
• 출판사 소개

ksm

영문 목차

영문목차

Global Substance Abuse Treatment Market is estimated to be valued at USD 11.82 Bn in 2025 and is expected to reach USD 21.33 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 11.82 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.80%	2032 Value Projection:	USD 21.33 Bn

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics:

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Detailed Segmentation:

• Global Substance Abuse Treatment Market, By Type
  • Alcohol
  • Opioids (e.g., heroin, prescription painkillers)
  • Tobacco/nicotine
  • Cocaine
  • Marijuana
  • Methamphetamines
  • Other illicit drugs (Benzodiazepines, etc.)
• Global Substance Abuse Treatment Market, By Treatment Type
  • Opioid
  • Methadone
  • Buprenorphine
  • Extended-release naltrexone
  • Lofexidine
  • Nicotine
  • Nicotine replacement therapies (available as a patch, inhaler, or gum)
  • Bupropion
  • Varenicline
  • Alcohol
  • Naltrexone
  • Disulfiram
  • Acamprosate
  • Tobacco
  • Clonidine
  • Nortriptyline
  • Others (Topiramate, Modafinil, etc.)
• Global Substance Abuse Treatment Market, By Age Group
  • Adolescents
  • Adults
  • Geriatric
• Global Substance Abuse Treatment Market, By Treatment Setting
  • Outpatient Treatment
  • Outpatient Clinics
  • Private Practices
  • Inpatient Treatment
  • Rehabilitation Centers
  • Hospitals
  • Residential Treatment Facilities
  • Detoxification Centers
• Global Substance Abuse Treatment Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Indivior PLC
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Treatment Type
  • Market Snippet, By Age Group
  • Market Snippet, By Treatment Setting
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing consumption of drugs and alcohol
• Growing support from government and NGOs
  • Restraints
• Social stigma associated with substance dependence
• Lack of adequate rehabilitation facilities
  • Opportunities
• Untapped markets in developing countries
• Company Market Share Analysis
• Key Highlights
• Market Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Substance Abuse Treatment Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Opioids (e.g., heroin, prescription painkillers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tobacco/nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cocaine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Marijuana
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Methamphetamines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other illicit drugs (Benzodiazepines, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Substance Abuse Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Opioid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Methadone
• Buprenorphine
• Extended-release naltrexone
• Lofexidine
• Nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nicotine replacement therapies (available as a patch, inhaler, or gum)
• Bupropion
• Varenicline
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Naltrexone
• Disulfiram
• Acamprosate
• Tobacco
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Clonidine
• Nortriptyline
• Others (Topiramate, Modafinil, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Substance Abuse Treatment Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Substance Abuse Treatment Market, By Treatment Setting, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Outpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Outpatient Clinics
• Private Practices
• Inpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Rehabilitation Centers
• Hospitals
• Residential Treatment Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Detoxification Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Substance Abuse Treatment Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Indivior PLC
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us

관련자료